GlassScriptPhysician profile
Charles Daniel Benson
NPI 1003044033
$3,233.17
in general payments reported to CMS, 2019-2025
25 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $938 · 2021: $396 · 2022: $299 · 2023: $265 · 2024: $221 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,033.62 | 2019-2025 | Iconix |
| Depuy Synthes Sales INC. | $777.01 | 2019-2023 | |
| Smith+Nephew, INC. | $321.25 | 2019-2024 | Stravix Mesh, Stravix Pl, Oasis |
| Amgen INC. | $265.73 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $140.37 | 2019-2023 | |
| Pacira Therapeutics, INC. | $92.13 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $76.72 | 2019-2023 | Xiaflex |
| Carbofix Orthopedics INC | $64.36 | 2025 | |
| Axogen | $56.78 | 2019-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Abbvie INC. | $47.53 | 2023-2024 | Dalvance |
| Kerecis Limited | $42.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $40.76 | 2021 | |
| Horizon Therapeutics Plc | $39.52 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $35.58 | 2019-2023 | |
| Ethicon US, LLC | $33.84 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $28.54 | 2025 | Cmf |
| Osiris Therapeutics INC. | $23.86 | 2019 | |
| Radius Health, INC. | $19.24 | 2020 | |
| Zimmer Biomet Holdings, INC. | $17.72 | 2019 | |
| Abbott Laboratories | $17.31 | 2024 | Eterna |
| Integra Lifesciences Corporation | $16.35 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sanara Medtech INC. | $13.63 | 2023 | Celleraterx |
| Breg, INC | $13.06 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Kci USA, INC. | $12.72 | 2019 | |
| Stability Biologics, LLC | $3.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.